\n\n5 mg \/ ml injection solution
biperidenlaktat<\/p>\n\n\n\n
Akineton is a so-called anticholinergic drug used to treat Parkinson’s disease. The drug can also be used for so-called extrapyramidal symptoms that have arisen due to other drug use.<\/p>\n\n\n\n
Talk to your doctor or pharmacist before using Akineton.
<\/p>\n\n\n\n
Take special care with Akineton if you have an enlarged prostate, an increased risk of cramps and palpitations.<\/p>\n\n\n\n
Elderly people may be more sensitive to this type of medicine and the dose may need to be adjusted by a doctor.<\/p>\n\n\n\n
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.<\/p>\n\n\n\n
Concomitant use of Akineton and other anticholinergic drugs such as neuroleptics(medicines for nervous system diseases), antihistamines (medicines for allergies ), antiparkinsonian medicines, antispasmodics (antispasmodics), quinidine (heart medicine), and levodopa (medicines for Parkinson’s disease ) may strengthen side effects of the drugs.<\/p>\n\n\n\n
You should avoid drinking alcohol during treatment with Akineton.<\/p>\n\n\n\n
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.<\/p>\n\n\n\n
Pregnancy<\/em><\/p>\n\n\n\n Limited experience of use during pregnancy. Breast-feeding<\/em><\/p>\n\n\n\n Biperiden passes into breast milk and may affect the breast-feeding baby. Breast-feeding is not recommended when using Akineton.<\/p>\n\n\n\n Akineton may reduce the reactivity of some patients and may therefore affect your ability to drive or use tools or machines. You are responsible for assessing whether you are fit to drive a motor vehicle or perform work that requires sharpened attention. One of the factors that can affect your ability in these respects is the use of drugs due to their effects and\/or side effects. Descriptions of these effects and side effects can be found in other sections. Read all the information in this leaflet for guidance. If you are not sure, talk to your doctor or pharmacist.<\/p>\n\n\n\n This medicine contains less than 1 mmol (23 mg) sodium per ampoule, ie essentially ‘sodium-free’.<\/p>\n\n\n\n This medicine is given to you by a doctor or other healthcare professional.<\/p>\n\n\n\n Dose one is determined by the doctor, who adjusts it individually for you.<\/p>\n\n\n\n Older people may need a lower dose. Akinetone 5 mg\/ml solution for injection is injected into a muscle or given slowly intravenously.<\/p>\n\n\n\n If you have any further questions on the use of this product, ask your doctor or pharmacist.<\/p>\n\n\n\n Like all medicines, this medicine can cause side effects, although not everybody gets them.<\/p>\n\n\n\n Side effects can occur especially at the beginning of treatment and if the dose is increased too quickly. Rare (may affect up to 1 in 1,000 people):<\/em><\/p>\n\n\n\n In higher doses, the following side effects may occur upset mood, anxiety, fear, confusion, hallucinations, and insomnia. Central stimulant effects are common in patients with symptoms of mental retardation and may require a dose reduction. Very rare (may affect up to 1 in 10,000 people):<\/em><\/p>\n\n\n\n No known frequency (cannot be calculated from the available data):<\/em><\/p>\n\n\n\n Reporting of side effects ar<\/em><\/p>\n\n\n\n If you get any side effects, talk to your doctor, pharmacist, or nurse. This also applies to any side effects not mentioned in this information. You can also report side effects directly (see details below). By reporting side effects, you can help increase drug safety information. The Medical Products Agency<\/p>\n\n\n\n Box 26<\/p>\n\n\n\n 751 03 Uppsala<\/p>\n\n\n\n Reporting of side effects<\/em><\/p>\n\n\n\n If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Medical Products Agency, www.lakemedelsverket.se. By reporting side effects, you can help increase drug safety information. <\/p>\n\n\n\n Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiration date is the last day of the specified month. No special storage instructions. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.<\/p>\n\n\n\n Pack sizes: 5×1 ml, glass ampoule<\/p>\n\n\n\n Laboratorio Farmaceutico SIT, Srl<\/p>\n\n\n\n Via Cavour, 70<\/p>\n\n\n\n 27035 Co (PV)<\/p>\n\n\n\n Italy Information provided by:<\/em><\/strong><\/p>\n\n\n\n POA Pharma Scandinavia AB<\/p>\n\n\n\n Box 24026<\/p>\n\n\n\n 400 22 Gothenburg Tel. 031-788 05 99<\/p>\n\n\n\n info@poaab.com This leaflet was last amended on 2018-08-24<\/p>\n\n\n\n Dosage and route of administration<\/em><\/strong> Parkinsonism:<\/em> In severe cases, 2 (\u20134) ampoules [10 (\u201320) mg] intramuscularly or slowly intravenously, distributed throughout the day.<\/p>\n\n\n\n Drug-induced extrapyramidal symptoms<\/em> ( acute dystonia and initial dyskinesia ):<\/p>\n\n\n\n In acute dystonia, \u00bd \u2013 1 ampoule (2.5\u20135 mg) is given intramuscularly or slowly intravenously. The extrapyramidal symptoms may disappear already during injection one. In these cases, the injection should be stopped. If necessary, the prescribed dose can be given again after 30 minutes.<\/p>\n\n\n\n Incompatibilities<\/em><\/strong><\/p>\n\n\n\n The solution for injection should not be mixed with other medicines, as miscibility studies are not available<\/p>\n","protected":false},"excerpt":{"rendered":" Akineton is a so-called anticholinergic drug used to treat Parkinson’s disease. The drug can also be used for so-called extrapyramidal symptoms that have arisen due to other drug use.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"cybocfi_hide_featured_image":"","footnotes":""},"categories":[2201,2200],"tags":[11292,11295,11287,11290,11296,11291,11294,11289,11293,11288],"class_list":["post-5060","post","type-post","status-publish","format-standard","hentry","category-a","category-medicines","tag-akineton","tag-akineton-injection","tag-biperidenlaktat","tag-biperidenlaktat-injection","tag-side-effects-of-akineton","tag-side-effects-of-biperidenlaktat","tag-what-akineton-is-used-for","tag-what-biperidenlaktat-is-used-for","tag-what-is-akineton","tag-what-is-biperidenlaktat"],"_links":{"self":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/5060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/comments?post=5060"}],"version-history":[{"count":4,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/5060\/revisions"}],"predecessor-version":[{"id":13006,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/5060\/revisions\/13006"}],"wp:attachment":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/media?parent=5060"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/categories?post=5060"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/tags?post=5060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
<\/p>\n\n\n\nDriving and using machines<\/h2>\n\n\n\n
<\/p>\n\n\n\nAkinetone contains sodium<\/h2>\n\n\n\n
3. How to use Akineton<\/h2>\n\n\n\n
<\/p>\n\n\n\n4. Possible side effects<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n5. How to store Akineton<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n6. Contents of the packaging and other information<\/h2>\n\n\n\n
Content declaration<\/h2>\n\n\n\n
What the medicine looks like and the contents of the pack<\/h2>\n\n\n\n
Marketing Authorization Holder and Manufacturer<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\nThe following information is intended for healthcare professionals only:<\/h2>\n\n\n\n
<\/p>\n\n\n\n